Praxis Precision Medicines, Inc.
NASDAQPraxis Precision Medicines delivered the week's most striking biotech setup: a 17% rally on the back of a positive earnings reaction, yet short sellers — who hold nearly 16% of the float — have barely moved. The most telling detail this week is what shorts did not do. Short interest edged up just 1.4% over the week to roughly 15.9% of free float, despite the stock climbing from…
Snapshot as of 20 Aug 2026
Praxis Precision Medicines delivered the week's most striking biotech setup: a 17% rally on the back of a positive earnings reaction, yet short sellers — who hold nearly 16% of the float — have barely moved. The most…
Praxis Precision Medicine enters the final stretch before its June 10 earnings with options defensiveness at a year-long peak — even as short sellers quietly reduce their exposure. The options market is flashing its…
Praxis Precision Medicine heads into mid-May with a sharpening divergence between a cautious short base and a bullish analyst consensus that just got a fresh upward nudge. Short interest is meaningfully elevated but…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PRAX — free to start on ORTEX.
Sign up for free →Open PRAX on ORTEX